Logo image
Noninvasive diffuse optical measurement of blood flow and blood oxygenation for monitoring radiation therapy in patients with head and neck tumors: a pilot study
Journal article   Open access   Peer reviewed

Noninvasive diffuse optical measurement of blood flow and blood oxygenation for monitoring radiation therapy in patients with head and neck tumors: a pilot study

Ulas Sunar, Harry Quon, Turgut Durduran, Jun Zhang, Juan Du, Chao Zhou, Guoqiang Yu, Regine Choe, Alex Kilger, Robert Lustig, …
Journal of Biomedical Optics, v 11(6), pp 064021-0640213
22 Nov 2006
PMID: 17212544
url
https://www.spiedigitallibrary.org/journals/journal-of-biomedical-optics/volume-11/issue-6/064021/Noninvasive-diffuse-optical-measurement-of-blood-flow-and-blood-oxygenation/10.1117/1.2397548.pdfView
Published, Version of Record (VoR) Open
url
https://doi.org/10.1117/1.2397548View
Published, Version of Record (VoR) Open

Abstract

diffuse optics head and neck tumors therapy monitoring tissue oxygenation Blood Flow
This pilot study explores the potential of noninvasive diffuse correlation spectroscopy (DCS) and diffuse reflectance spectroscopy (DRS) for monitoring early relative blood flow (rBF), tissue oxygen saturation (StO2), and total hemoglobin concentration (THC) responses to chemo-radiation therapy in patients with head and neck tumors. rBF, StO2, and THC in superficial neck tumor nodes of eight patients are measured before and during the chemo-radiation therapy period. The weekly rBF, StO2, and THC kinetics exhibit different patterns for different individuals, including significant early blood flow changes during the first two weeks. Averaged blood flow increases (52.7±9.7)% in the first week and decreases (42.4±7.0)% in the second week. Averaged StO2 increases from (62.9±3.4)% baseline value to (70.4±3.2)% at the end of the second week, and averaged THC exhibits a continuous decrease from pretreatment value of (80.7±7.0) [μM] to (73.3±8.3) [μM] at the end of the second week and to (63.0±8.1) [μM] at the end of the fourth week of therapy. These preliminary results suggest daily diffuse-optics-based therapy monitoring is feasible during the first two weeks and may have clinical promise.

Metrics

5 Record Views
132 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Biochemical Research Methods
Optics
Radiology, Nuclear Medicine & Medical Imaging
Logo image